COVID-19 Persistence in Stool

NCT04546776 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-06-17

No results posted yet for this study

Summary

This is a longitudinal study in which participants that have been confirmed by a National Health Service (NHS) swab test as COVID-19 positive will be asked to provide faecal and saliva samples, and complete short health/lifestyle questionnaires at the time of sampling (referred to as a sample set). The number of sample sets collected from any participant will be dependent on how long the SARS-CoV-2 virus persists within the stool. The investigators aim to collect a minimum of 4 and a maximum of 8 sample sets, and will target all COVID-19-positive subjects, with the exception of those severally ill (e.g. in the intensive care unit (ICU)). The investigators aim to recruit a minimum of 100 and up to 200 participants. To obtain the desired numbers, it may be necessary to continue recruitment during any further United Kingdom (UK) COVID-19 infection peaks.

Conditions

  • SARS-CoV Infection

Sponsors & Collaborators

  • Norfolk and Norwich University Hospitals NHS Foundation Trust

    collaborator OTHER
  • James Paget University Hospital NHS Foundation Trust

    collaborator OTHER
  • Quadram Institute Bioscience

    lead OTHER

Principal Investigators

  • Arjan Narbad, BSc, PhD · Quadram Institute Bioscience

  • Ngozi Franslem-Elumogo, MBBS, DTM&H, FRCPath · Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)

  • Andreas Brodbeck, PhD, FRCA, FICM · James Paget University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-08
Primary Completion
2024-11-30
Completion
2025-05-09

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04546776 on ClinicalTrials.gov